Cardinals Rumors: Should St. Louis consider a Chris Sale trade?

Chris Sale is an interesting trade target for the Cardinals

When it comes to upgrading the top end of the St. Louis Cardinals rotation for 2023, the options are thin at best. Currently, most of the top end pitchers that fans would want them to target (Tyler Glasnow, Shane Bieber, Max Fried, etc.) are just not available at the moment. Could they hit the trade block later this year? Potentially. But at the moment, the next time the Cardinals will have an opportunity to acquire an ace is next off-season.

There is one name that could be available this winter that would make for a very interesting buy low option, who could pay big dividends for St. Louis on their path toward a postseason run. After losing Xander Bogaerts in free agency and a Rafael Devers trade looming, the Boston Red Sox may want to move off of left-hander Chris Sale and the rest of his contract.

Let's address a couple of the elephants in the room before really looking into this. Yes, Sale is not the same pitcher he was from 2013-2018, where he finished top 6 in Cy Young voting ever single year. This is not the same as acquiring one of the top pitchers currently in the game. Second, his contract his huge, so any move for Sale would require the Red Sox to take on significant salary and/or eat up some of Sale's money.

With these things in mind, there is a really good case to be made that Boston could be motivated to deal Sale in the near future, and that the Cardinals would make a great landing spot, assuming the Red Sox eat money in this deal. Let's look at why Boston and St. Louis would consider this move, and what a potential deal could look like.

Chris Sale still has the ability to lead the Cardinals rotation

The idea of trading for a starter who has been battling injuries might be unthinkable for some, but as we will get into, the cost to acquire Sale will be nowhere near the price of other starters on the market, and likely would not even remove St. Louis from the market for a "reliable ace".

Over the last two seasons, Sale has battled those freak injuries, limiting him to just 11 starts. He has still produced in those 48.1 innings, posting a 3.17 ERA and elite 10.6 strikeouts per nine innings. It's not like Sale has lost the ability to pitch, he just had maybe some of the worst injury luck in baseball history as of late.

It's one thing to acquire a starter with nagging elbow or shoulder issues. Those things are not just fluky, they are prone to continue. Yes, Sale had Tommy John surgery, but pitchers come back from that all the time now, and he has shown he is still close to his old form post surgery. The only thing that has been standing in his way is line drives and bike accidents.

With no clear options available on the market, why not take a swing at a guy who could very easily return to his elite form and give you an ace for the next 2-3 seasons, on what would be a bargain contract after Boston eats some of it. Sale has 2-years, $55 million left on his deal with a vesting option for 2025 at $20 million if he "places top 10 in Cy Young voting and remains healthy". Due to a bunch of deferments in his contract though, he only makes $17 million per year the next two years and $15 million in the vesting year.

Here is how St. Louis and Boston could come to an agreement that would benefit both sides for 2023 and beyond

Paul DeJong and prospect for Chris Sale and money

The Red Sox have a need at shortstop now, and there has been speculation from Boston media that Paul DeJong could be a target for them. Why not swap the money from his contract and a prospect for the services of Chris Sale?

In this deal, the Cardinals acquire sale and $10 million to offset some of his money in 2023 and 2024 in exchange for DeJong and left-handed hitting prospect Alec Burleson. Sale immediately slots into the Cardinals rotation as their number two starter, giving them a five man group that has the potential to matchup well with other rotations in baseball. If Sale continues to battle injuries or struggles, his salary hit will be low enough that it was worth the risk for the Cardinals.

For Boston, they shed future money from their books but also take a flyer on DeJong, who if he regains his form in a change of scenery, they would have two club options to utilize on him moving forward. If not, they can decline those and let him walk. They also acquire Burleson, who would be a great DH/1B/corner OF option for them and his bat would project really well in Fenway Park.

The Cardinals have an abundance of young bats at the moment, and it is likely one of Burleson or Juan Yepez will not be on the big league roster this season when Jordan Walker makes his debut. Using him as a piece to potentially grab an elite starter makes a lot of sense for St. Louis.

Would you take a flyer on Chris Sale, assuming the contract is eaten some and the price point is low? If so, would you do this deal? Let me know in the comments below.